Brief: SpectraCure Q3 Loss After Tax Narrows To SEK 4.7 Mln
17/11/2023 08:14
Nov 17 (Reuters) - SpectraCure AB SPEC.ST :
* REPORTED ON THURSDAY Q3 OTHER OPERATING INCOME SEK 0.6 MLN
VS
SEK 0.7 MLN YR AGO
* Q3 LOSS AFTER TAX SEK 4.7 MLN VS LOSS SEK 5.6 MLN YR AGO
* BOARD HAS NOW DECIDED TO APPLY FOR PERMISSION TO INITIATE
CLINICAL TRIALS FOR PRIMARY LOCALISED PROSTATE CANCER IN US, UK,
CANADA, SWEDEN
* GOAL IS TO START CLINICAL STUDY IN FIRST HALF OF 2024
Source text for Eikon: urn:newsml:reuters.com:*:nMFN2nZWKY
Further company coverage: SPEC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))